Literature DB >> 3315203

Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

H Yamaue1, M Katsumi, K Tabuse, Y Tabuse, K Kuribayashi, T Nishihara, K Saito.   

Abstract

The present study shows that natural killer cell-mediated cytotoxicity of BALB/c mouse spleen cells to syngeneic tumor cells was augmented by in vivo priming or in vitro stimulation with the streptococcal preparation OK432. The augmentation of spleen cell cytotoxicity to syngeneic tumor cells by in vivo priming alone with OK432 was lower than that obtained by in vitro stimulation alone with OK432. When the murine spleen cells primed in vivo with OK432 were rechallenged in vitro with OK432 at various intervals, the natural cytotoxicity was more strongly enhanced than that seen with in vitro stimulation alone. The cell surface phenotype of killer cells activated with OK432 was Thy 1+ and asialo GM1+, suggesting the activated natural killer cell. Next, mice were transplanted with syngeneic colon adenocarcinoma cells, and primed in vivo with OK432. These spleen cells were subsequently challenged in vitro with OK432. These spleen cells displayed a strong cytotoxic activity not only to the transplanted adenocarcinoma cells but also to other syngeneic tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315203     DOI: 10.1007/BF00199143

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  26 in total

1.  Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.

Authors:  M Hoyer; T Meineke; W Lewis; B Zwilling; J Rinehart
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

2.  Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.

Authors:  A Uchida
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-02

Review 3.  Passive immunotherapy of cancer in animals and man.

Authors:  S A Rosenberg; W D Terry
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

4.  Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.

Authors:  A Uchida; E Klein
Journal:  Immunol Lett       Date:  1985       Impact factor: 3.685

5.  Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes.

Authors:  M Saito; T Ebina; M Koi; T Yamaguchi; Y Kawade; N Ishida
Journal:  Cell Immunol       Date:  1982-03-15       Impact factor: 4.868

6.  Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes.

Authors:  J V Zielske; S H Golub
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

7.  Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice.

Authors:  G L Andriole; J J Mulé; C T Hansen; W M Linehan; S A Rosenberg
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

8.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.

Authors:  K Oshimi; S Kano; F Takaku; K Okumura
Journal:  J Natl Cancer Inst       Date:  1980-12       Impact factor: 13.506

9.  Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.

Authors:  A Uchida; M Micksche; T Hoshino
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro.

Authors:  M Saito; T Yamaguchi; T Ebina; M Koi; E Aonuma; H Usami; N Ishida
Journal:  Cell Immunol       Date:  1983-06       Impact factor: 4.868

View more
  4 in total

1.  The antitumour activity of the interferon inducer bropirimine is partially mediated by endogenous tumour necrosis factor alpha.

Authors:  M Scheringa; J N IJzermans; J Jeekel; R L Marquet
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Authors:  M Tani; H Tanimura; H Yamaue; M Iwahashi; T Tsunoda; M Tamai; K Noguchi; K Arii
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; H Tanimura; M Iwahashi; M Tani; T Tsunoda; K Tabuse; K Kuribayashi; K Saito
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Fibronectin promotes the proliferation of cytotoxic T lymphocytes generated from cancer patients.

Authors:  S Mizobata; H Tanimura; H Yamaue; M Tani; T Tsunoda; M Iwahashi; K Noguchi; N Nishimoto; T Hotta; K Arii
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.